Production (Stage)
Ultralife Corporation
ULBI
$5.46
-$0.07-1.27%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 15.72% | 22.86% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 15.72% | 22.86% | |||
| Cost of Revenue | 14.28% | 23.10% | |||
| Gross Profit | 20.25% | 22.08% | |||
| SG&A Expenses | -2.07% | 19.60% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.78% | 22.03% | |||
| Operating Income | 187.91% | 60.84% | |||
| Income Before Tax | 394.14% | 40.23% | |||
| Income Tax Expenses | 116.41% | 254.05% | |||
| Earnings from Continuing Operations | 706.44% | -16.49% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 64.10% | -85.71% | |||
| Net Income | 861.34% | -24.81% | |||
| EBIT | 187.91% | 60.84% | |||
| EBITDA | 103.04% | 36.92% | |||
| EPS Basic | 858.12% | -24.52% | |||
| Normalized Basic EPS | 1,288.41% | -67.76% | |||
| EPS Diluted | 937.74% | -31.61% | |||
| Normalized Diluted EPS | 1,304.41% | -67.77% | |||
| Average Basic Shares Outstanding | 0.02% | 0.02% | |||
| Average Diluted Shares Outstanding | -0.49% | -0.66% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||